<DOC>
	<DOC>NCT00689039</DOC>
	<brief_summary>The purpose is to study the safety and tolerability of increasing doses of AZD1305 and how the medication is metabolised by the body (how it is taken up, distributed, and how it disappears from the body). The study is performed in healthy volunteers.</brief_summary>
	<brief_title>Study of an Extended Release (ER) Tablet, Single and Repeated Dosing</brief_title>
	<detailed_description />
	<criteria>A body mass index (BMI=weight/height2) of 19 to 27 kg/m2 Clinically normal physical findings, laboratory values and resting ECG as judged by the investigator ECG findings outside normal range Potassium outside normal reference values</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>multiple ascending doses</keyword>
	<keyword>Safety and pharmacokinetics</keyword>
</DOC>